Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
09/15/1994 | WO1994020481A1 4-amino-2-(hetero)aryl-butanamides useful as 5-ht1a-antagonists |
09/15/1994 | WO1994020472A1 Heterocyclic compounds, their use and preparation |
09/15/1994 | WO1994020471A1 Quinolone derivatives as dopamine d4 ligands |
09/15/1994 | WO1994020470A1 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
09/15/1994 | WO1994020466A1 Novel 2-phenoxy ethylamine derivatives, their preparation and their therapeutical use |
09/15/1994 | WO1994020465A1 Indole derivatives as antagonists of excitatory amino acids |
09/15/1994 | WO1994020459A2 Pyrrolo-pyridine derivatives as dopamine receptor ligands |
09/15/1994 | WO1994020454A1 New derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning |
09/15/1994 | WO1994020133A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
09/15/1994 | WO1994020110A1 Use of antiepileptics such as carbamazepine and oxcarbazepine for treating aids-related neural disorders |
09/15/1994 | WO1994020109A1 Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists |
09/15/1994 | WO1994020108A1 Use of lamotrigine for treating aids-related neural disorders |
09/15/1994 | WO1994020103A1 Use of riluzole for treating aids-related neural disorders |
09/15/1994 | WO1994020086A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
09/15/1994 | WO1994020062A2 Balanoids as protein kinase c inhibitors |
09/15/1994 | WO1994016705A3 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
09/15/1994 | WO1994015598A3 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
09/15/1994 | WO1994011394A3 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
09/15/1994 | CA2158037A1 Oligodendroglial trophic factor and methods of use thereof |
09/15/1994 | CA2157580A1 Heterocyclic compounds and their preparation and use |
09/15/1994 | CA2157412A1 Balanoids |
09/15/1994 | CA2157359A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
09/15/1994 | CA2157357A1 New sulfated lyso-ganglioside derivatives |
09/15/1994 | CA2156410A1 Pyrrolo-pyridine derivatives |
09/15/1994 | CA2156409A1 Quinolone derivatives as dopamine d4 ligands |
09/15/1994 | CA2156389A1 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
09/15/1994 | CA2154573A1 Use of anticonvulsants for the treatment of neuro-sida |
09/15/1994 | CA2154571A1 Use of lamotrigine for the treatment of neuro-sida |
09/15/1994 | CA2153951A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-one-1,1-dioxide derivatives as non- competitive nmda receptor antagonists |
09/15/1994 | CA2152400A1 New 2-phenoxyethanamine derivatives; process for preparing them and their use as therapeutic agents |
09/14/1994 | EP0614913A2 Dynorphin derivatives |
09/14/1994 | EP0614911A1 Compounds having a sulfonamide and an amidinegroup, process for preparation and pharmaceutical compositions comprising them |
09/14/1994 | EP0614893A1 Benzoazine derivatives, their preparation and their use in therapy |
09/14/1994 | EP0614888A1 Tetrahydrocyclopent[b]indole methanamines and related compounds, a process for their preparation and their use as medicaments |
09/14/1994 | EP0614659A2 Pharmaceutical compositions in semisolid form and a device for administration thereof |
09/14/1994 | EP0614363A1 Quinolone derivatives |
09/14/1994 | EP0518960B1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them |
09/13/1994 | US5347013 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles |
09/13/1994 | US5346916 Alkoxy-3-[(Toluenesulfonylaminoalkyl)amino] chroman compounds |
09/13/1994 | US5346906 Substituted pyridines, their preparation, formulations and use in dementia |
09/13/1994 | US5346903 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
09/13/1994 | US5346896 1-(aryl or heteroaryl)-4[ω-(aryl or heteroaryl)ω-(aryl or heteroaryl)alkylene]piperazines |
09/13/1994 | US5346894 Treatment of lyso PAF-mediated diseases with PAF antagonists and procedure for determining their efficacy |
09/13/1994 | CA1331991C Imidazo/2,1-b/benzothiazoles useful in the treatment of memory disorders and/or irritable conditions |
09/09/1994 | CA2117164A1 Tetrahydrocyclopent¬b|indole methanamines and related compounds, a process for their preparation and their use as medicaments |
09/09/1994 | CA2117122A1 Benzoxazine derivatives, their preparation, and their application in therapy |
09/07/1994 | EP0613898A1 Aryl or arylalkyl-carbonyl heterocyclic derivatives, processes for their preparation and compositions containing them |
09/07/1994 | EP0613560A1 A method for assaying and treating alzheimer's disease |
09/07/1994 | EP0613472A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
09/07/1994 | EP0613465A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
09/07/1994 | EP0613459A1 N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists. |
09/07/1994 | EP0613458A1 Acyclic ethylenediamine derivatives as substance p receptor antagonists |
09/07/1994 | EP0422068B1 Pharmacological treatment of ocular development |
09/07/1994 | CN1091743A Pyrrole Derivative, Preparation of same and application of same in medical treatment |
09/07/1994 | CN1091733A Anti-androgenic cyclo and bicyclo alkenes |
09/07/1994 | CN1091636A Medicaments |
09/07/1994 | CN1091635A 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzole as anti-depression pharmaceutical |
09/07/1994 | CN1025857C Benodizaepine compounds and their use as pharmaceuticals |
09/07/1994 | CN1025853C Antithromotic compounds |
09/06/1994 | US5344915 Proteins and the preparation thereof |
09/06/1994 | US5344835 Piperidine and pyrrolidine derivatives |
09/06/1994 | US5344828 Piperazinealkanoic acid and a pharmaceutical composition comprising the same |
09/06/1994 | US5344826 Tricycle steroid analogs |
09/06/1994 | US5344648 Central nervous system activator and taste enhancing food additive |
09/06/1994 | CA2116881A1 (aryl(alkyl)carbonyl) heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
09/06/1994 | CA1331877C Aminopropanol derivatives of 3-(3-hydroxyphenyl)-1- propanone compounds, process for preparing same, and pharmaceutical compositions containing said compounds |
09/02/1994 | CA2116213A1 Pyrrolo-pyridine derivatives |
09/01/1994 | WO1994019493A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
09/01/1994 | WO1994019356A1 Silylated acetylcholinesterase inhibitors |
09/01/1994 | WO1994019354A1 Chemical compounds |
09/01/1994 | WO1994019349A1 Xanthine derivatives as adenosine a1 receptor antagonists |
09/01/1994 | WO1994019348A1 Bicyclic nitrogenous compound |
09/01/1994 | WO1994019325A1 Coupling product obtained from hystamine and an amino acid |
09/01/1994 | WO1994019323A1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists |
09/01/1994 | WO1994019316A1 New compounds |
09/01/1994 | WO1994019315A1 New compounds |
09/01/1994 | CA2157041A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
09/01/1994 | CA2156186A1 Chemical compounds |
09/01/1994 | CA2152925A1 Azacyclic compounds compositions containing them and their use as tachykinin antagonists |
08/31/1994 | EP0612845A2 Purified opioid receptor |
08/31/1994 | EP0612730A1 O-aryl ethers of morphinans |
08/31/1994 | EP0612323A1 Cns active tetrahydrobenzothienopyridines |
08/31/1994 | EP0612321A1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
08/31/1994 | EP0612318A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
08/31/1994 | EP0612314A1 2-heterocyclicethylamine derivatives and their use as pharmaceuticals |
08/31/1994 | EP0612242A1 Methods and compositions utilizing pure s(+) isomer fluoxetine |
08/31/1994 | EP0496796B1 Method and compositions for inhibition of disorders associated with oxidative damage |
08/30/1994 | USRE34712 Pharmaceutically useful (+)-1-(3-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydroiso benzofuran-5-carbonitrile and non-toxic acid addition salts thereof |
08/30/1994 | US5342960 Inhibit synthesis and release of histamine |
08/30/1994 | US5342949 2 step process for preparing biologically active tropane derivatives and starting material therefore |
08/30/1994 | US5342848 Thioformamide derivatives |
08/30/1994 | US5342627 Controlled release device |
08/30/1994 | CA1331756C Process for the manufacture of bi-2h-pyrroli(di)nediones |
08/24/1994 | EP0611769A1 Silylated acetylcholinesterase inhibitors |
08/24/1994 | EP0611766A1 Polysubstituted 2-amido thiazoles derivatives, process for their preparation, pharmaceutical compositions and utilization for the preparation of a medicament |
08/24/1994 | EP0611765A1 2-(Imidazol-1-yl)-3-heteroarylpropylidene-aminoxyalkanoic acid derivatives |
08/24/1994 | EP0611569A2 Triglycerides |
08/24/1994 | EP0611370A1 Pyridine-3-carboxylic acid esters or amides useful as 5-ht 3? antagonists |
08/24/1994 | EP0473671B1 Use of sigma-receptors ligands for the manufacture of an anxiolytic agent |
08/24/1994 | EP0471761B1 Use of a GnRHanalog for the manufacture of a medicament for the treatment of motility disorders |